Breaking News, Financial News

Financial Report: Syneos Health

Results include combined INC Research and inVentiv merger

By: Kristin Brooks

Managing Editor, Contract Pharma

Syneos Health
4Q Revenues: $1.1 billion (revenues were $406.1 million 4Q16)
4Q Loss: $15.0 million (earnings were $37.5 million 4Q16)
FY Revenues: $2.7 billion (revenues were $1.6 billion FY16)
FY Loss: $138.5 million (earnings were $112.6 million FY16)
Comments: Combined Company new business awards were $622.9 million in the quarter and $2.55 billion for the full year 2017 representing growth of 16.5% for the full year 2017. Combined Company book-to-bill ratio of 1.16x for the quarter and 1.20x for the full year 2017. The combined company includes financial information of INC Research and inVentiv Health.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters